The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.
about
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasisGalphaq directly activates p63RhoGEF and Trio via a conserved extension of the Dbl homology-associated pleckstrin homology domainG Protein-Coupled Receptors in CancerCUX1 transcription factor is a downstream effector of the proteinase-activated receptor 2 (PAR2)Identification of potential small molecule binding pockets on Rho family GTPasesThrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61.Binding of the WASP/N-WASP-interacting protein WIP to actin regulates focal adhesion assembly and adhesionZyxin is involved in thrombin signaling via interaction with PAR-1 receptorThe Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growthTransformation by a nucleotide-activated P2Y receptor is mediated by activation of Galphai, Galphaq and Rho-dependent signaling pathways.Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA.The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis.Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis.Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.The effect of therapeutic anticoagulation on overall survival in men receiving first-line docetaxel chemotherapy for metastatic castration-resistant prostate cancer.Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma.Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cellsG-protein signaling: back to the futureThrombin promotes sustained signaling and inflammatory gene expression through the CDC25 and Ras-associating domains of phospholipase CϵProtease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasionProtease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastomaThrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222G protein-coupled receptors go extracellular: RhoA integrates the integrins.Regulation and physiological functions of G12/13-mediated signaling pathways.A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.Role of G12 proteins in oncogenesis and metastasisSignaling mechanisms that regulate smooth muscle cell differentiation.Rho GTPases modulate malignant transformation of tumor cells.Platelet-targeted pharmacologic treatments as anti-cancer therapy.Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis.Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs).Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment.A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion.Thrombin induces nitric-oxide synthase via Galpha12/13-coupled protein kinase C-dependent I-kappaBalpha phosphorylation and JNK-mediated I-kappaBalpha degradation.
P2860
Q24652518-2306E9FE-B481-4B0D-B96A-8BE73D2DF1CAQ24658016-4CA7C459-2869-42D9-970E-109F3E34CEEFQ26741203-FADCE879-D763-4AC7-A97B-5933E0567354Q28298716-D86101B1-D811-4D94-AAD5-895AEF3D2524Q28481320-AE27C4C6-52B4-4A2A-8A07-20B1B1A79B75Q30413746-44A84056-BF98-4635-8045-10A3B6FFE8C0Q30583693-38915188-765F-437D-9F9F-82C1EB545C91Q33613240-1BCB33C1-F250-485C-BA1F-D646FF3D094CQ33792985-22C396E1-5CBC-4123-BF85-4A58E84DD33BQ34049631-6C13DED1-51F8-4FB2-B75F-263A784AD7CBQ34148307-26512F45-3CB8-47F7-9CA1-E2A223425458Q34280883-A37E7D77-570E-4AFE-9986-177F8AD64655Q34650253-E0A973E4-DC81-4D83-8DBD-8D95AA4A68B5Q34722924-258FBD2C-659B-4245-9EAB-3D2961275CB7Q35070124-EB939028-D097-4CC6-9615-611217F16694Q35078198-4D4C4464-FA72-4D56-84DA-A72715AA843FQ35095964-195B30EA-B148-42FE-904A-A05703740B01Q35678312-A96B5BB8-644D-46A2-817D-BC11A595A203Q35749110-1A3C1A47-24F0-4184-8FF1-378DF52366F7Q36061579-49DD1326-581E-43DA-B3D8-CF000A8BDF64Q36283751-F4DBC6E2-E254-4FA7-BEFB-E631082071A3Q36322931-B2CEDB40-0965-47C5-B655-AB6611FB10BAQ36420521-EC9EC06B-5F8A-49BA-ABCA-42DCF3F6605CQ37000605-4ADFBF79-361F-4AD2-A77D-37F385054426Q37033314-DB24E395-ACC5-408A-AD56-8929C2F4B68FQ37188430-94A85EC6-D110-43DB-93E8-8A41F994E555Q37284426-750CAFFF-68DB-499E-A59A-79F1B885675DQ37391229-CF9E7186-6D00-44DB-8DCA-481D6EE140C6Q37459121-5C26F1B8-A263-4285-8287-8D26B9C89096Q37473484-7E361BE5-FFC0-4F37-9E27-12ECD6663431Q37890184-36168D7F-3FEE-47D9-8A13-F6F790F9A9D6Q38230951-21121F6C-5913-435E-B288-524AE1C9481AQ38657846-20D8C0CA-3900-429D-928C-656F43E02B4AQ38836736-67FC9E86-6514-4625-82F6-F997D3BFA7D4Q39209792-E2CA8560-AD32-422F-9C8F-97B514D036A2Q39279928-B52EB57C-90AC-48C1-AFB9-EC8FFFAEAD41Q39433833-47B22E5A-309C-4269-AA55-089B34331F73Q39900071-DD806527-FD73-4595-B5FC-AC2EFBB7B23AQ40264901-F2333DFF-C093-4086-B7FA-A463DA9AD63CQ40667979-776975AB-8A6E-4142-9FAB-589EC9A5F013
P2860
The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The thrombin receptor, PAR-1, ...... o-mediated signaling pathways.
@ast
The thrombin receptor, PAR-1, ...... o-mediated signaling pathways.
@en
type
label
The thrombin receptor, PAR-1, ...... o-mediated signaling pathways.
@ast
The thrombin receptor, PAR-1, ...... o-mediated signaling pathways.
@en
prefLabel
The thrombin receptor, PAR-1, ...... o-mediated signaling pathways.
@ast
The thrombin receptor, PAR-1, ...... o-mediated signaling pathways.
@en
P2093
P2860
P356
P1433
P1476
The thrombin receptor, PAR-1, ...... o-mediated signaling pathways.
@en
P2093
Klinger MB
Whitehead IP
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204281
P407
P577
2001-04-01T00:00:00Z
P5875
P6179
1016979695